It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.

CVS Health (NYSE:CVS) shares extended six straight sessions of losses, as the stock slipped 0.9% at $63.26 on Thursday. The healthcare company fell 4.3% in the preceding six sessions. The stock has ...